Rachel Besser

Has grant

Honorary senior clinical lecturer

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Rachel Besser is an Honorary Senior Clinical Lecturer at the Wellcome Centre for Human Genetics in the United Kingdom. Her research focuses on the management and monitoring of type 1 diabetes in children and adolescents, with recent articles addressing topics such as best practice recommendations, disease progression testing methods, and innovative treatment options including closed-loop insulin delivery systems. Dr. Besser is also involved in the development of consensus guidance for managing individuals with islet autoantibody-positive pre-stage 3 type 1 diabetes.

Recent Grants

Grant: Close

Screening for pre-clinical Type 1 diabetes to prevent hospital admission and acute illness at diagnosis: determining the evidence for benefit, acceptability and elements relevant to cost evaluation

Open Date: 2022-10-01

Close Date: 2023-12-01

Grant: Close

A feasibility study to establish antibody screening in primary care at the time of the pre school vaccination to prevent decompensated type 1 diabetes presentation in childhood

Open Date: 2020-09-01

Close Date: 2021-09-01

Grant: Close

Testing the feasibility and acceptability of EarLy Surveillance for Autoimmune diabetes: The ELSA Study

Open Date: 2020-06-01

Close Date: 2025-06-01

Articles (25)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (19)

Philip Evans

Professor of Primary Care Research

University of Exeter

UNITED KINGDOM

Rachel Besser

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (25)

Testing methods used to predict disease progression in children with early-stage type 1 diabetes: A systematic review and meta-analysis

Considerations for more actionable consensus guidance for monitoring individuals with islet autoantibody-positive pre-stage 3 type 1 diabetes. Reply to Mallone R [letter]

UK best practice recommendations for children and young people <18 years with pre‐stage 3 type 1 diabetes, on behalf of the British Society for Paediatric Endocrinology and Diabetes (BSPED)

Trends in Total Daily Dose and Variability of Insulin Requirements in Newly Diagnosed Children and Adolescents with Type 1 Diabetes over 48 Months

Cost-Effectiveness of Closed-Loop Automated Insulin Delivery Using the Cambridge Hybrid Algorithm in Children and Adolescents with Type 1 Diabetes: Results from a Multicenter 6-Month Randomized Trial

Consensus guidance for monitoring individuals with islet autoantibody-positive pre-stage 3 type 1 diabetes

Correction to: Consensus guidance for monitoring individuals with islet autoantibody‑positive pre‑stage 3 type 1 diabetes

Effect of 48 Months of Closed-Loop Insulin Delivery on Residual C-Peptide Secretion and Glycemic Control in Newly Diagnosed Youth With Type 1 Diabetes: A Randomized Trial

General population screening for type 1 diabetes using islet autoantibodies at the preschool vaccination visit: a proof-of-concept study (the T1Early study)

Consensus Guidance for Monitoring Individuals With Islet Autoantibody–Positive Pre-Stage 3 Type 1 Diabetes

The effect of closed-loop glucose control on C-peptide secretion in youth with newly diagnosed type 1 diabetes: the CLOuD RCT

Diabetic Ketoacidosis at Onset of Type 1 Diabetes and Glycemic Outcomes with Closed-Loop Insulin Delivery

Clinical care advice for monitoring of islet autoantibody positive individuals with presymptomatic type 1 diabetes.

Transdermal Blood Sampling for C-Peptide Is a Minimally Invasive, Reliable Alternative to Venous Sampling in Children and Adults With Type 1 Diabetes

Closed-Loop Therapy and Sleep in Young People Newly Diagnosed With T1D and Their Parents

Closed-Loop from Diagnosis of Type 1 Diabetes in Children and Young People

Time spent in hypoglycemia according to age and time-of-day: Observations during closed-loop insulin delivery.

What does the licensing of teplizumab mean for diabetes care?

General population screening for childhood type 1 diabetes: is it time for a UK strategy?

ISPAD Clinical Practice Consensus Guidelines 2022: Stages of type 1 diabetes in children and adolescents

Evaluating the Impact of Applying Personal Glucose Targets in a Closed-Loop System for People With Type 1 Diabetes.

Safety of User-Initiated Intensification of Insulin Delivery Using Cambridge Hybrid Closed-Loop Algorithm.

The emotional well-being of parents with children at genetic risk for type 1 diabetes before and during participation in the POInT-study.

Closed-Loop Therapy and Preservation of C-Peptide Secretion in Type 1 Diabetes.

Lived experience of CamAPS FX closed loop system in youth with type 1 diabetes and their parents.

Collaborators (19)

Philip Evans

Jennifer Couper

Kirstine Bell

Åke Lernmark

Mikael Knip

Laura M. Jacobsen

kristina casteels

Michael J. Haller

Anna Long

Helen Colhoun

Paul Wadwa

Juan J Madrid-Valero

Charlotte Boughton

Ezio Bonifacio

Julia Townson

Sze Ng

Lalantha Leelarathna

Tatjana Nikolic

Maria E Craig

Make your next move.